PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 72 filers reported holding PASSAGE BIO INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,327,767 | -30.1% | 2,017,883 | 0.0% | 0.00% | – |
| Q2 2023 | $1,899,433 | -1.7% | 2,017,883 | 0.0% | 0.00% | – |
| Q1 2023 | $1,932,527 | -30.6% | 2,017,883 | 0.0% | 0.00% | – |
| Q4 2022 | $2,784,679 | +10.5% | 2,017,883 | +0.0% | 0.00% | – |
| Q3 2022 | $2,521,000 | -42.1% | 2,017,050 | +9.4% | 0.00% | – |
| Q2 2022 | $4,351,000 | -19.1% | 1,843,513 | +6.3% | 0.00% | – |
| Q1 2022 | $5,378,000 | -55.8% | 1,734,894 | -9.4% | 0.00% | – |
| Q4 2021 | $12,161,000 | -38.4% | 1,915,086 | -3.4% | 0.00% | – |
| Q3 2021 | $19,751,000 | -20.0% | 1,983,044 | +6.4% | 0.00% | -100.0% |
| Q2 2021 | $24,682,000 | +3.9% | 1,864,133 | +37.2% | 0.00% | 0.0% |
| Q1 2021 | $23,753,000 | -5.9% | 1,358,902 | +37.7% | 0.00% | 0.0% |
| Q4 2020 | $25,233,000 | +271.6% | 986,794 | +90.5% | 0.00% | – |
| Q3 2020 | $6,790,000 | -52.8% | 517,902 | -1.7% | 0.00% | -100.0% |
| Q2 2020 | $14,395,000 | +7853.0% | 526,734 | +4505.5% | 0.00% | – |
| Q1 2020 | $181,000 | – | 11,437 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,959,769 | $6,844,481 | 14.16% |
| Lynx1 Capital Management LP | 3,355,917 | $4,631,165 | 4.00% |
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $3,447,132 | 2.50% |
| BML Capital Management, LLC | 337,467 | $465,704 | 0.44% |
| Frazier Life Sciences Management, L.P. | 3,756,915 | $5,184,543 | 0.32% |
| Orbimed Advisors | 8,931,999 | $12,326,159 | 0.24% |
| Newtyn Management, LLC | 790,000 | $1,090,200 | 0.22% |
| Oasis Management Co Ltd. | 240,000 | $331,200 | 0.07% |
| Rubric Capital Management LP | 822,105 | $1,134,505 | 0.05% |
| Marquette Asset Management, LLC | 67,101 | $92,599 | 0.03% |